2025
SJR Q1
JCR Q1 · 11,7
OA
3 matched articles
SCIE
Journal detail
Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ Publishing Group
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
20511426
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 4,114
- Quartile Q1
- H-Index 155
- Cites/doc 9,58
- Docs (3y) 1.437
- Cites (3y) 14.995
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 11,7
- 5Y JIF 12,3
- JCI 2,28
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q1
- Immunology Q1
- Immunology and Allergy Q1
- Molecular Medicine Q1
- Oncology Q1
- Pharmacology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Immunology and Microbiology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Oncology | Immunology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 4,114 | 11,7 | 12,3 | 2,28 | Q1 | 155 |
| 2024 | Q1 | Q1 | 4,22 | 10,6 | 11,5 | 2,15 | Q1 | 136 |
| 2023 | Q1 | Q1 | 3,728 | 10,3 | 11,6 | 2,02 | Q1 | 136 |
| 2022 | Q1 | Q1 | 3,403 | 10,9 | 12,6 | 1,9 | Q1 | 136 |
| 2021 | Q1 | Q1 | 3,45 | 12,5 | 13,9 | 1,97 | Q1 | 136 |
| 2020 | Q1 | Q1 | 5,06 | 13,8 | 13,9 | 2,29 | Q1 | 136 |
| 2019 | Q1 | Q1 | 4,194 | 10,3 | — | 2,04 | Q1 | 136 |
| 2018 | — | Q1 | — | 8,7 | — | 1,7 | Q1 | — |
| 2017 | Q1 | Q1 | 2,798 | 8,4 | — | 1,42 | Q1 | 136 |
| 2016 | Q1 | — | 2,668 | — | — | — | — | 136 |
| 2015 | Q1 | — | 1,929 | — | — | — | — | 136 |
| 2014 | Q3 | — | 0,486 | — | — | — | — | 136 |
| 2013 | — | — | — | — | — | — | — | 136 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q1 | Q1 | 9/183 |
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 30/333 |
| 2024 | IMMUNOLOGY | SCIE | Q1 | Q1 | 12/183 |
| 2024 | ONCOLOGY | SCIE | Q1 | Q1 | 27/328 |
| 2023 | IMMUNOLOGY | SCIE | Q1 | Q1 | 12/181 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q1 | 27/322 |
| 2022 | IMMUNOLOGY | SCIE | Q1 | Q1 | 18/161 |
| 2022 | ONCOLOGY | SCIE | Q1 | Q1 | 30/241 |
| 2021 | IMMUNOLOGY | SCIE | Q1 | Q1 | 18/162 |
| 2021 | ONCOLOGY | SCIE | Q1 | Q1 | 25/245 |
| 2020 | IMMUNOLOGY | SCIE | Q1 | Q1 | 8/162 |
| 2020 | ONCOLOGY | SCIE | Q1 | Q1 | 15/242 |
| 2019 | IMMUNOLOGY | SCIE | Q1 | Q1 | 10/159 |
| 2019 | ONCOLOGY | SCIE | Q1 | Q1 | 16/244 |
| 2018 | IMMUNOLOGY | SCIE | Q1 | Q1 | 12/158 |
| 2018 | ONCOLOGY | SCIE | Q1 | Q1 | 19/230 |
| 2017 | IMMUNOLOGY | SCIE | Q1 | Q1 | 13/155 |
| 2017 | ONCOLOGY | SCIE | Q1 | Q1 | 18/223 |